five research grants awarded totaling award recipients summaries listed award targeting toxicity sbma modulation usp activity anna pluciennik ph department biochemistry molecular biology thomas jefferson university summary polyq expanded androgen receptor dependent cellular toxicity neuromuscular system characteristic feature sbma pathogenesis although molecular mechanisms effects poorly understood however cellular toxicity sbma likely arise least part polyq expanded dependent dysregulation protein protein interactions sustain normal cellular function reasoned identification dysregulated interactions might help reveal potential therapeutic targets disease modification therefore part kda funded project used quantitative proteomics approach identified deubiquitinating enzyme usp preferentially interacts polyq expanded contributes toxicity fact demonstrated partial knockdown usp protein expression decrease mutant dependent aggregation dihydrotestosterone dependent cytotoxicity also overexpression protein aggravates cellular effects results establish need investigation role deubiquitinating function usp sbma pathogenesis objective research investigate functional consequence pharmacological inhibition usp deubiquitinase activity cellular mouse models sbma studies extend previous kda funded proteomics work successful establish validity inhibition usp activity therapeutic approach treatment sbma award identification new polyglutamine specific mutant interacting proteins sbma motor neurons xia feng postdoctoral fellow neurogenetics branch national institute neurological disorders stroke national institute health summary spinal bulbar muscular atrophy sbma slowly progressive neuromuscular disease disease proceeds nerve cells spinal cord called motor neurons start die muscle cells waste away causative mutation sbma mutant androgen receptor abnormal expansion certain region aberrant expansion mutant protein called polyglutamine tract damages normal function protein well obtains toxicity thus important understand mutant regulated via proteins disease i propose use human induced pluripotent stem cell model generate disease relevant motor neuron like cells use cells identify specific interacting proteins mutant androgen receptor i hoping research help provide motor neuron specific basis designing developing novel therapeutics treatment sbma award transcellular regulation proteostasis network kennedy disease laura bott ph postdoctoral fellow molecular biosciences northwestern university summary misfolding abnormal accumulation mutant androgen receptor kennedy disease indicates cellular machinery controlling protein abundance folding transport proteostasis may defective disease planning study molecular mechanisms kennedy disease worm caenorhabditis elegans genetically engineer worms express mutant androgen receptor neuromuscular system assess effects polyglutamine expansion proteostasis regulation model organism insights cell type specific effects regulation across tissues may lead new therapeutic approaches disease award one gene many proteins investigating role isoform therapeutic target sbma carlo rinaldi md phd department physiology anatomy genetics university oxford summary activity steroid hormone receptors progesterone oestrogen receptors modulated number isoforms splice variants tissue specific manner health disease androgen receptor may exception isoform molecular weight encoded widely expressed protein naturally occurring isoform arising use alternative transcriptional start site intron gene containing short unique seven amino acid long terminal stretch instead long terminal domain found full length overarching aim proposal unravel contribution isoform sbma pathogenesis provide novel therapeutic target disease suitable oligonucleotide antisense targeting without running risks associated silencing available copy gene males award use induced stem cells microfluidics developing new assays identify new therapies kennedy disease thomas durcan ph assistant professor montreal neurological institute mcgill university summary important explore new avenues search treatments kennedy disease kd overall goal develop disease relevant assays use human motor neurons made stem cells men kennedy disease healthy individuals using special silicone microfluidic devices grow motor neurons measure function neurons upon exposure different compounds first develop assays measure survival growth motor neurons next look well mitochondria work move within neurons finally aim set assay test ability normal kd motor neurons form synapses junctions taken together innovative assays provide foundation build kd drug discovery platform screen promising compounds targets treat kd